drugset

drugset / Trial / NCT03558477

PK/PD Clinical Trial of YYD601 in Healthy Adult Male

NCT03558477 ↗

Phase 1 Completed 30 enrolled Yooyoung Pharmaceutical Co., Ltd.

RandomizedParallel-groupOpen-labelTreatment

Summary

A dose block-randomized, open-label, parallel clinical trial

Timeline

Start: 2017-09-19
Primary completion: 2018-02-07
Completion: 2018-02-07

Publications

Lee HW, Kang WY, Jung W, Gwon MR, Cho K, Yoon YR, Seong SJ. Pharmacokinetics and Pharmacodynamics of YYD601, a Dual Delayed-Release Formulation of Esomeprazole, Following Single and Multiple Doses in Healthy Adult Volunteers Under Fasting and Fed Conditions. Drug Des Devel Ther. 2022 Mar 6;16:619-634. doi: 10.2147/DDDT.S338131. eCollection 2022.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Esomeprazole	Small molecule	30 mg	Oral
Subject	Esomeprazole	Small molecule	40 mg	Oral
Subject	Esomeprazole	Small molecule	60 mg	Oral

Indications